ArticleCureus2026
Breast Cancer Metastases Presenting as Musculoskeletal Complaints.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer often metastasizes to the bone, leading to musculoskeletal symptoms that may mimic benign conditions. Patients with undiagnosed or recurrent malignancies may initially present to first-contact providers, including chiropractors, with non-specific spinal or musculoskeletal pain. Here, we extend the series with two additional cases, highlighting risks of delayed diagnosis, the role of imaging, and chiropractic care. In Case 1, a 62-year-old woman with a history of breast carcinoma presented with progressive left-sided sciatica-like symptoms (pain radiating from the sacroiliac region to the lower extremity), revealing progressive metastases on MRI (e.g., L5 vertebral collapse with retropulsion and severe stenosis) and PET/CT (e.g., new intraspinal extensions at C2, T2, and T4). Multidisciplinary intervention, including radiotherapy, targeted therapy (letrozole, palbociclib, denosumab), and conservative chiropractic management, reduced Visual Analog Scale (VAS) pain scores from 7/10 to 3/10 and improved quality of life from 58/100 to 86/100. In Case 2, a 44-year-old woman presented with constant lumbar pain (7/10 intensity), leading to the discovery of multilevel vertebral collapses (e.g., C7, T3, T5, T8, and L2) and abnormal marrow signals on MRI, confirmed as invasive ductal carcinoma via biopsy and PET/CT. These cases underscore the need for vigilance in patients with an oncologic history presenting with musculoskeletal pain. These clinical outcomes highlight the synergy of an interdisciplinary management model, where primary oncology therapies (radiotherapy and systemic targeted agents) successfully achieve metabolic and structural stabilization of the metastatic lesions, while concurrent, low-force supportive chiropractic care safely focuses on mechanical symptom mitigation and preserving the patient's quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.